Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: a population-based cohort study in England
Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.
Leggi
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Survodutide for treatment of obesity: baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1)
le Roux CW, Wharton S, Bozkurt B, et al.
Diabetes Obes Metab. Pub. online 4 Nov 2025.
Leggi
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
Billings LK, Hsia S, Bays H, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
Gitelman SE, Simmons K, Sherr JL, et al.
Diabetologia. Pub. online 6 Nov 2025.
Leggi
Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes
Henney AE, Heague M, Riley DR, et al.
Diabetes Obes Metab. Pub. online 3 Nov 2025.
Leggi
Screening natriuretic peptide levels predicts heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure
Pop-Busui R, Repetto E, Baron J, et al.
Diabetes Care. Pub. online 30 Oct 2025.
Leggi
Systematic review and meta-analysis corrected for history of smoking tobacco identifies type 1 diabetes as a possible risk factor for bladder cancer
Bennett HO, Bogumil D, Kysh L, et al.
Diabetes Res Clin Pract. 2025:112976.
Leggi
Pharmacological therapies for type 2 diabetes: future approaches
Bailey CJ
Diabetologia. Pub. online 31 Oct 2025.
Leggi